Abstract
The duration and severity of the allergic response are variable. Even though antigens are rapidly cleared from the individual, an acute allergic response is frequently followed by a recrudescence of symptoms hours or even days after the initial exposure. Experimentally, the cellular infiltrates and mediators released during this late response resemble those associated with chronic inflammatory disease. Although basophils are present in this late reaction, the stimuli for their activation remain unknown. A heterogeneous group of unique cytokines called histamine-releasing factors (HRF), discovered over a decade ago, may well play a role in stimulating basophils during this late-phase reaction. These factors have been reported from a variety of cell sources including alveolar macrophages, platelets, vascular endothelial cells, B and T lymphocytes, mononuclear cell cultures, the U937 monocyte/macrophage-like cell line and the RPMI 8866 B cell line. These ubiquitous factors cause non-cytotoxic, calcium-dependent mediator release from human basophils in vitro and are also present and active in vivo. Purification attempts have revealed that HRF exists in at least three forms, based on molecular weight. In our hands, the mechanism of mediator release by one of the forms of HRF is IgE dependent. Since only about 50% of allergic donors' basophils respond to HRF, a heretofore unappreciated heterogeneity of IgE was revealed. The presence of HRF has been shown to correlate with severity of allergic disease in children with food allergies, with symptoms in the late-phase response in adults and with severity of the allergic response to an inhaled antigen. Thus, the study of HRF has evolved over the last decade and may lead to better understanding of the complex allergic response.
Similar content being viewed by others
References
Alam R, Rozniecki J (1985) A mononuclear cell-derived histamine-releasing factor in asthmatic patients. Allergy 40: 124
Alam R, Rozniecki J, Salmaj K (1984) A mononuclear cell-derived histamine-releasing factor (HRF) in asthmatic patients. Histamine release from basophils in vitro. Ann Allergy 53: 66
Alam R, Kuna P, Rozniecki J, Kuzminska B (1987) The magnitude of the spontaneous production of histamine-releasing factor (HRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthma. J Allergy Clin Immunol 79: 103
Alam R, Grant JA, Lett-Brown MA (1988) Identification of a histamine-release inhibitory factor produced by human mononuclear cells in vitro. J Clin Invest 82: 2056
Alam R, Welter JB, Forsythe PA, Lett-Brown MA, Grant JA (1989) Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-γ, granulocyte macrophage-colony-stimulating factor, tumor necrosis factor-α and histamine-releasing factors on the secretion of histamine from basophils. J Immunol 142: 3431
Baenzinger J, Kornfeld S (1974) Structure of the carbohydrate units of IgE immunoglobulin. J Biol Chem 249: 1889
Baeza ML, Haak-Frendscho M, Satnick S, Kaplan AP (1988) Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol 141: 2688
Baeza ML, Reddigari S, Haak-Frendscho M, Kaplan AP (1989) Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest 83: 1204
Baeza ML, Reddigari S, Kornfeld D, Gorevic P, Kaplan AP (1989) Histamine-releasing factor(s) (HRF) from human mononuclear cells: further characterization and preparation of monoclonal antibodies. J Allergy Clin Immunol 83: 237
Baeza ML, Reddigari S, Kornfeld D, Ramani N, Smith EM, Hossler PA, Castor CW, Gorevic PG, Kaplan AP (1989) Relationship of one form of human histamine-releasing factor (HRF) to connective tissue activating peptide III (CTAP-III). Clin Res 37: 55A
Bamzai AK, Kretschmer RR (1978) Enhancement of antigen-induced leukocyte histamine release by a mononuclear cell-derived factor. J Allergy Clin Immunol 62: 137
Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM (1988) The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of systemic steroid pretreatment. Am Rev Respir Dis 138: 406
Battey J, Max EE, McBride WO, Swan D, Leder P (1982) A processed human immunoglobulin E gene has moved to chromosome 9. Proc Natl Acad Sci USA 79: 5956
Behrens BL, Clark RAF, Marsh W, Larsen GL (1984) Modulation of the late asthmatic response by antigen-specific immunoglobulin G in an animal model. Am Rev Respir Dis 130: 1134
Blackley CH (1959) Experimental researches on the causes and nature of catarrhus aestivus (hayfever or hay asthma) 1873. Bailliere, Tindell and Cox, London, pp 77–81
Bochner BS, Charlesworth EN, Lichtenstein LM, Gillis S, Dinarello C, Schleimer RP (1990) Interleukin-1 (IL-1) is released during the cutaneous allergic late-phase response (LPR) to antigen (Ag). FASEB J (in press)
Charlesworth EN, Iliopoulos O, MacDonald SM, Kagey-Sobotka A, Lichtenstein LM (1989) Cells and secretagogues involved in the human late-phase response. Int Arch Allergy Appl Immunol 88: 50
Creticos PS, Peters SP, Adkinson NF, Naclerio RM, Hayes EC, Norman PS, Lichtenstein LM (1984) Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 310: 1626
Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J (1973) Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 52: 38
Durham SR, Lee TH, Cromwell O, Shaw RJ, Merrett TG, Merrett J, Cooper P, Kay AB (1984) Immunologic studies in allergen-induced late phase asthmatic reactions. J Allergy Clin Immunol 74: 49
Eidinger D, Wilkinson R, Rose B (1964) A study of the cellular response in the immune reaction utilizing the skin window technique. J Allergy 35: 77
Ezeamuzie IC, Assem ESK (1983) A study of histamine release from human basophils and lung mast cells by products of lymphocyte stimulation. Agents Actions 13: 222
Felarca AB, Lowell FC (1971) The accumulation of eosinophils and basophils at skin sites as related to intensity of skin reactivity and symptoms of atopic disease. J Allergy Clin Immunol 48: 125
Findlay SR, Dvorak AM, Kagey-Sobotka A, Lichtenstein LM (1981) Hyperosmolar triggering of histamine release from human basophils. J Clin Invest 67: 160
Fisher RH, Weiss M, Kagey-Sobotka A, Lichtenstein LM, Adkinson N (1988) Response to platelet-derived histamine-releasing factor (PD-HRF) is associated with allergic but not non-allergic asthma. Int Cong Allergology Clin Immunol (ICACI) 9: 249
Grant JA, Dupree E, Goldman AS, Schultz DR, Jackson AL (1975) Complement-mediated release of histamine from human leukocytes. J Immunol 144: 1101
Guo C-B, Liu MC, Galli SJ, Kagey-Sobotka A, Lichtenstein LM (1990) The histamine containing cells in the late-phase response in the lung are basophils. J Allergy Clin Immunol (in press)
Haak-Frendscho M, Aral N, Arai K-I, Baeza ML, Finn A, Kaplan AP (1988) Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest 82: 17
Ida S, Hook JJ, Siraganian RP, Notkins A (1980) Enhancement of IgE-mediated histamine release from human basophils by immunospecific lymphokines. Clin Exp Immunol 41: 380
Iliopoulos O, Proud D, Lichtenstein LM, Kagey-Sobotka A, Reticos PS, Adkinson NF, Mac-Donald SM, Norman PS, Naclerio RM (1987) Relationship between early (ER), late (LPR) and rechallenge (RCR) responses to nasal challenge. J Allergy Clin Immunol 79: 253
Ishizaka T, Ishizaka K (1974) Mechanisms of passive sensitization. IV. Dissociation of IgE molecules from basophil receptors at acid pH. J Immunol 112: 1078
Kagey-Sobotka A, Dembo M, Goldstein B, Lichtenstein LM (1979) Antigen-specific desensitization of human basophils. J Immunol 122: 511
Kaplan AP, Haak-Frendscho M, Fauci A, Dinarello C, Halbert E (1985) A histamine-releasing factor from activated human mononuclear cells. J Immunol 135: 2027
Kuna P, Alam R, Kuzminska B, Rozniecki J (1989) The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal assthma: results of a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol 83: 816
Lett-Brown MA, Thueson DO, Plank DE, Duffy L, Grant JA (1984) Histamine-releasing activity. V. Characterization and purification using high-performance liquid chromatography. Cell Immunol 87: 445
Lett-Brown MA, Thueson DO, Plank DE, Langford MP, Grant JA (1984) Histamine-releasing activity. IV. Molecular heterogeneity of the activity from stimulated human thoracic duct lymphocytes. Cell Immunol 87: 434
Liu MC, Proud D, Lichtenstein LM, MacGlashan DW, Schleimer RP, Adkinson NF, Kagey-Sobotka A, Schulman ES, Plaut M (1986) Human macrophage-derived histamine releasing activity is due to IgE-dependent factors. J Immunol 136: 2588
Lohman IC, Halonen M (1986) Purification of rabbit serum IgE. Fed Proc 45: 388
MacDonald SM, Lichtenstein LM, Proud D, Plaut M, Naclerio RM, MacGlashan DW, Kagey-Sobotka A (1987) Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 139: 506
MacDonald SM, Kagey-Sobotka A, Proud D, Naclerio RM, Lichtenstein LM (1987) Histaminereleasing factor release mechanism and responding population. J Allergy Clin Immunol 79: 248
MacDonald SM, Schleimer RP, Kagey-Sobotka A, Gillis S, Lichtenstein LM (1989) Recombinant IL-3 induces histamine release from human basophils. J Immunol 142: 3527
MacGlashan DW Jr, Mogowski M, Lichtenstein LM (1983) Studies of antigen binding on human basophils. II. Continued expression of antigen specific IgE during antigen-induced desensitization. J Immunol 130: 2337
Mackiewicz A, Ganapathi MK, Schultz D, Kushner I (1987) Monokines regulate glycosylation of acute-phase proteins. J Exp Med 166: 253
Massey WA, Randall TC, Kagey-Sobotka A, Warner JA, MacDonald SM, Gillis S, Allison AC, Lichtenstein LM (1989) Recombinant human interleukin 1α and 1β potentiate IgE-mediated histamine release from human basophils. J Immunol 143: 1875
McLean J, Garkowski A, Solomon W, Matthews K (1971) Changes in airway resistance on antigen challenge in allergic rhinitis. Clin Allergy 1: 63
Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Meyers DA, Norman PS, Lichtenstein LM (1983) Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 128: 597
Naclerio RM, Togias A, Proud D, Kagey-Sobotka A, Adkinson NF, Plaut M, Norman PS, Lichtenstein LM (1985) Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 313: 65
Nagy L, Lee TH, Kay AB (1982) Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med 306: 497
Orchard MA, Kagey-Sobotka A, Proud D, Lichtenstein LM (1986) Basophil histamine release induced by a substance from stimulated platelets. J Immunol 136: 2240
Pene J, Rousset F, Briere F, Chretien I, Bonnefoy J-Y, Spits H, Yokota T, Arai N, Arai K-I, Banchereau J, De Vries JE (1988) IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α. and prostaglandin E2. Proc Natl Acad Sci USA 85: 6880
Pepys J, Turner-Warwick M, Dawson PL, Hinton KFW (1968) Arthus (type III) skin test reactions in man. Clinical and immunopathological features. Proceedings of the 6th Congress of the International Association of Allergology. Excerpta Med Int Congr Ser 162: 221
Peterson BA, Nilsson A, Stalenheim G (1975) Induction of histamine release and desensitization in human leukocytes. J Immunol 114: 1581
Plaut M, Liu MC, Conrad DH, Proud D, MacGlashan DW, Kagey-Sobotka A, Lichtenstein LM (1986) Histamine release from human basophils is induced by IgE-dependent factor(s) derived from human lung macrophages and an Fcε receptor-positive human B cell line. Trans Assoc Am Phys 98: 305
Pruzansky JJ, Grammer LC, Patterson R, Roberts M (1983) Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release. J Immunol 131: 1949
Sampson HA, Broadbent KR, Bernhisel-Broadbent J (1989) Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 321: 228
Sarfati M, Luo H, Delespesse G (1989) IgE synthesis by chronic lymphocytic leukemia cells. J Exp Med 170: 1775
Schleimer RP, Gillespie E, Lichtenstein LM (1981) Release of histamine from human leukocytes stimulated with the tumor promoting phorbol esters. J Immunol 126: 570
Schulman ES, Proud D, Liu MC, MacGlashan DW, Lichtenstein LM, Plaut M (1985) Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis 131: 230
Sedgwick JD, Holt PG, Turner KI (1981) Production of a histamine-releasing lymphokine by antigen or mitogen stimulated human peripheral T cells. Clin Exp Immunol 45: 399
Shampain MP, Behrens BL, Larsen GL, Henson PM (1982) Animal model of late pulmonary responses to Alternaria challenge. Am Rev Respir Dis 126: 493
Siraganian RP, Hook WA (1977) Mechanism of histamine release by formyl methionyl containing peptides. J Immunol 119: 2078
Solley GO, Gleich GJ, Jordan RE, Schroeter AL (1976) Late phase of the immediate wheal and flare skin reaction: its dependence on IgE antibodies. J Clin Invest 54: 408
Strickland DB, Turner KJ, Holt BJ, Niemensma NP (1988) Histamine-releasing factor-Cellular source and kinetics of production are influenced by characteristics of antigen. Allergy Proc 9: 317
Subramanian N, Bray MA (1987) Interleukin 1 causes histamine release from human basophils and mast cells in vitro. J Immunol 138: 271
Thueson DO, Speck LS, Lett-Brown MA, Grant JA (1979) Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 123: 626
Thueson DO, Speck LS, Lett-Brown MA, Grant JA (1979) Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol 123: 633
Thueson DO, Plank PE, Langford MP, Lett-Brown MA, Grant JA (1982) Basophilic histamine release: lymphocyte-derived histamine-releasing activity. Fed Proc 4: 964
Valent P, Besemer J, Muhm M, Majdic O, Lechner K, Bettelheim P (1989) Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci USA 86: 5542
Warner JA, Pienkowski MM, Plaut M, Norman PS, Lichtenstein LM (1986) Identification of histamine-releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol 136: 2583
Weiss M, Fisher RH, Kagey-Sobotka A, Proud D, Lichtenstein LM, Adkinson NF (1988) In vivo response to platelet-derived histamine-releasing factor. J Allergy Clin Immunol 81: 224
Author information
Authors and Affiliations
Additional information
Figures 1–3 were printed by permission from the Journal of Immunology. These figures appeared in J Immunol 139: 506 (1987)
Rights and permissions
About this article
Cite this article
MacDonald, S.M., Lichtenstein, L.M. Histamine-releasing factors and heterogeneity of IgE. Springer Semin Immunopathol 12, 415–428 (1990). https://doi.org/10.1007/BF00225327
Issue Date:
DOI: https://doi.org/10.1007/BF00225327